venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 10
- +1 vs. Q4 2021
- Portfolio value
- $451.1M
- −$104.0M (−18.7%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $163.9M | 36.3% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,544,484 | $75.1M | 16.7% | −1,195,927−43.6% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 5,011,536 | $68.0M | 15.1% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 2,303,310 | $41.8M | 9.3% | 00.0% | Unchanged | History |
| CINCCinCor Pharma, Inc. | COM | 1,980,706 | $34.7M | 7.7% | +1,980,706 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 2,171,664 | $30.8M | 6.8% | 00.0% | Unchanged | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $17.6M | 3.9% | 00.0% | Unchanged | History |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 3,673,374 | $11.7M | 2.6% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,608,167 | $6.57M | 1.5% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 161,897 | $808.0K | 0.2% | 00.0% | Unchanged | History |